Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer communications (London, England)

Showing results (1-10 of 468) with videos related to

Pageof 47
Sort By:
Cancer Communications (London, England)|May 18, 2021
Identification of immune-activating metabolite for enhancing T cell therapy of cancerBoyi Cong, Zenghui Cui, Xuetao Cao
Cancer Communications (London, England)|May 3, 2020
Cancer burden of major cancers in China: A need for sustainable actionsMaomao Cao, He Li, Dianqin Sun, et al.
Cancer Communications (London, England)|May 3, 2020
Association between glioblastoma cell-derived vessels and poor prognosis of the patientsXin Mei, Yin-Sheng Chen, Qing-Ping Zhang, et al.
Cancer Communications (London, England)|May 12, 2020
Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real-world data analyses and experience of one centerQianyi Lu, Kaping Lee, Fei Xu, et al.
Cancer Communications (London, England)|April 12, 2020
Emerging role of deep learning-based artificial intelligence in tumor pathologyYahui Jiang, Meng Yang, Shuhao Wang, et al.
Cancer Communications (London, England)|April 18, 2020
Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapyWei Chang Colin Tan, Sanjna Nilesh Nerurkar, Hai Yun Cai, et al.
Cancer Communications (London, England)|September 21, 2022
An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatmentElena Verdugo, Iker Puerto, Miguel Ángel Medina
Cancer Communications (London, England)|January 4, 2022
Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1Dan Wu, Yi Yang, Yiran Hou, et al.
Cancer Communications (London, England)|March 10, 2021
Neoadjuvant immunotherapy for non-small cell lung cancer: State of the artJin Kang, Chao Zhang, Wen-Zhao Zhong
Cancer Communications (London, England)|November 5, 2021
Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective studyYa Wang, Long Qiao, Jie Yang, et al.
Pageof 47

Showing results (1-10 of 468) with videos related to

Sort By:
Pageof 47
Cancer Communications (London, England)|May 18, 2021
Identification of immune-activating metabolite for enhancing T cell therapy of cancerBoyi Cong, Zenghui Cui, Xuetao Cao
Cancer Communications (London, England)|May 3, 2020
Cancer burden of major cancers in China: A need for sustainable actionsMaomao Cao, He Li, Dianqin Sun, et al.
Cancer Communications (London, England)|May 3, 2020
Association between glioblastoma cell-derived vessels and poor prognosis of the patientsXin Mei, Yin-Sheng Chen, Qing-Ping Zhang, et al.
Cancer Communications (London, England)|May 12, 2020
Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real-world data analyses and experience of one centerQianyi Lu, Kaping Lee, Fei Xu, et al.
Cancer Communications (London, England)|April 12, 2020
Emerging role of deep learning-based artificial intelligence in tumor pathologyYahui Jiang, Meng Yang, Shuhao Wang, et al.
Cancer Communications (London, England)|April 18, 2020
Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapyWei Chang Colin Tan, Sanjna Nilesh Nerurkar, Hai Yun Cai, et al.
Cancer Communications (London, England)|September 21, 2022
An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatmentElena Verdugo, Iker Puerto, Miguel Ángel Medina
Cancer Communications (London, England)|January 4, 2022
Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1Dan Wu, Yi Yang, Yiran Hou, et al.
Cancer Communications (London, England)|March 10, 2021
Neoadjuvant immunotherapy for non-small cell lung cancer: State of the artJin Kang, Chao Zhang, Wen-Zhao Zhong
Cancer Communications (London, England)|November 5, 2021
Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective studyYa Wang, Long Qiao, Jie Yang, et al.
Pageof 47